https://www.selleckchem.com/products/cpypp.html
Lung cancer is the most common cause of death in all kinds of cancers in Japan, and the number of it increased year and year in these 50 years. Since the 5-year survival rate of advanced lung cancer is only 6.4%, it is one of the poorest prognosis cancers. Almost 70% of patients with advanced lung cancer is suggested to be in precachexia/cachexia stage at their diagnosis. Cancer cachexia is one of the major reasons of refractory to chemotherapy and cancer death, however there is no effective treatment developed. Because cancer cachexia is